Fierce Healthcare
NOVEMBER 11, 2021
10 rural states launch lawsuit against CMS' COVID-19 vaccine mandate for healthcare workers. dmuoio. Thu, 11/11/2021 - 12:57.
pharmaphorum
NOVEMBER 12, 2021
Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients. The MOATAI-VIR algorithm, developed by scientists at Emory University and Georgia Tech, was put through its paces in a study that showed it was able to predict 24 out of 26 clinical manifestations of COVID-19, including acute respiratory distress, blood clotting issues, cytokine storms, brain fog, and loss of sm
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
NOVEMBER 10, 2021
Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.
Pharma Marketing Network
NOVEMBER 8, 2021
November 3, 2021 – Tune in with the Pharma Marketing Network for an exciting conversation with R.J. Lewis and David Hunt, CEO of The Considered, as he shares how his new independent agency, The Considered, about how they are breaking the rules in pharma advertising. David discusses and answers questions around: How The Considered is different. What launched the conception of the agency?
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
NOVEMBER 6, 2021
Industry Voices—Why primary care is the future of sustainable healthcare in the U.S. hlandi. Sat, 11/06/2021 - 21:45.
pharmaphorum
NOVEMBER 8, 2021
The UK government has announced £248 million in spending over the next year for a project to make it easier for patient test results and scans to be shared between hospitals, labs and GP surgeries. The aim is to “digitise diagnostics care” across the NHS, reducing the time it takes to diagnose health problems and get treatment started earlier, helping to address the massive backlog in care caused by the pandemic, according to a Department of Health and Social Care (DHSC) statement.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
NOVEMBER 11, 2021
ChAdOxl biEBOV is being tested for safety and immunogenicity, and may protect against multiple species of the virus
Fierce Healthcare
NOVEMBER 12, 2021
Nominations open for Fierce Healthcare's Fierce 15 of 2022. pminemyer. Fri, 11/12/2021 - 10:15.
pharmaphorum
NOVEMBER 9, 2021
Scotland has given the green light to AstraZeneca’s Tagrisso for restricted use to treat adult patients with non-small cell lung cancer (NSCLC), making it the first country in the world to approve the routine use of the therapy in this setting. The Scottish Medicines Consortium (SMC) has approved Tagrisso (osimertinib) for use within NHS Scotland as a monotherapy for adjuvant treatment after tumour removal in adult patients with stage IB-IIIA NSCLC whose tumours have epidermal growth factor (EGF
Outsourcing Pharma
NOVEMBER 12, 2021
Johnson & Johnson today announced its intent to separate its Consumer Health business into a new publicly traded company: allowing J&J to put a sharpened focus on pharmaceuticals and medical devices.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
NOVEMBER 10, 2021
Janssen's Ponvory accepted for use within NHS Scotland for adults RRMS patients
Fierce Healthcare
NOVEMBER 9, 2021
Nearly 60% of health systems aim to become 'payviders' in 2022, survey finds. rking. Tue, 11/09/2021 - 13:51.
pharmaphorum
NOVEMBER 8, 2021
A single dose of the COVID-19 monoclonal antibody therapy developing Regeneron reduced the risk of contracting the virus by around 82% for up to eight months, according to new trial data. The results suggest that the REGEN-COV (casirivimab/imdevimab) antibody could play a key role in protecting people who do not mount a sufficiently strong immune response after COVID-19 vaccines, according to the company.
Outsourcing Pharma
NOVEMBER 8, 2021
The decentralized tech specialist has acquired Digital Artefacts, a research tech firm focused on cognitive, behavioral, and physiological data capture.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Turnkey Pharmacy Solutions
NOVEMBER 10, 2021
By Rob Nahoopii If you are like me, it feels like I have been on a roller coaster ride as I watch what is and what is not going to be included in the Social Reform Bill titled “Build Back Better Act” (BBBA) or H.R. 5376. I have also been having a hard time tracking.
Fierce Healthcare
NOVEMBER 8, 2021
How this telehealth startup aims to address mental illness with ketamine therapy. agliadkovskaya. Mon, 11/08/2021 - 13:17.
pharmaphorum
NOVEMBER 10, 2021
Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and environmental drivers, consequences, and data. AMR threatens to undermine “almost a century of health gains” and marshalling a response to such a problem “requires cooperation at many levels”. That’s according to a newly published report from the US National Academies of Sciences, Engineering, and Medicine, which calls for a One Health approach that recognises the scale of th
Outsourcing Pharma
NOVEMBER 10, 2021
According to the market intelligence firm, automation appeals to drug packaging and manufacturing firms, thanks to their productivity-boosting potential.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Mirror
NOVEMBER 10, 2021
Milan, CPhI Worldwide – hosted in-person at Fiera Milano, Italy (9-11 November, 2021) – opens its doors to international pharma for the first time in two years asindustry confidence surges to record highs according to executives in the CPhI Annual Survey. The survey insights are published as part of the CPhI Annual Report – which is launched each year at CPhI Worldwide – and compile the thoughts of over 370 executives from more than 30 countries.
Fierce Healthcare
NOVEMBER 12, 2021
Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm. pminemyer. Fri, 11/12/2021 - 18:06.
pharmaphorum
NOVEMBER 11, 2021
Shares in France’s Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two years, including 27 million next year. The deal for the adjuvanted, inactivated SARS-CoV-2 vaccine still depends on authorisation of the jab by the European Medicines Agency (EMA) which is due to start a rolling review of VLA2001 shortly, but Valneva thinks it could start delivering supplies to the EU in April next year.
Outsourcing Pharma
NOVEMBER 11, 2021
The infusion of funds in the Halle/Westfalen, Germany manufacturing complex is intended to help meet growing global demand for injectable pharmaceuticals.
Pharma Mirror
NOVEMBER 10, 2021
Milan, Ahead of the world’s largest pharma event – CPhI Worldwide taking place in Milan, Italy (9-11 November, 2021) – the third part of the CPhI Annual Report is released with key findings for biologics manufacturing, biotechs and CDMOs. CPhI experts – Dawn Ecker, Managing Director of bioTRAK Database Services at BDO and Fiona Barry, Editor at GlobalData PharmSource – look ahead to 2025 to predict the future demand for biologicals by volume, as well as the total capacity available and, the cons
Fierce Healthcare
NOVEMBER 10, 2021
Average family premiums rose 4% this year to $22K due to healthcare use decline: KFF. rking. Wed, 11/10/2021 - 15:09.
pharmaphorum
NOVEMBER 10, 2021
After being hailed as a triumph of public-private drug development, Moderna’s partnership with the US government on its COVID-19 vaccine looks like it may descend into acrimony. That is according to a New York Times report , which says Moderna is now in dispute with the National Institutes of Health (NIH) after it filed a US patent in the US that claims the company’s scientists invented the vaccine on their own.
Outsourcing Pharma
NOVEMBER 10, 2021
This capsule of industry news features Amcor, High Purity New England, MG America, and other firms offering packaging and labeling products and services.
The Spirit Pharmacist
NOVEMBER 6, 2021
Antidepressant and Psychedelic Interactions. The most common situations and clinical scenarios I consult about have to do with persons taking antidepressants that are interested in psychedelic therapies or have tried them while taking antidepressants with lackluster results. It’s truly a conundrum for serotonergic psychedelics as to how persons can best approach this work when the toughest part of it all may be weaning existing medications and getting the psychedelics to be potent and ther
Fierce Healthcare
NOVEMBER 10, 2021
Nametag launches automated COVID vaccination verification for employers. rtorrence. Wed, 11/10/2021 - 11:04.
pharmaphorum
NOVEMBER 10, 2021
Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine Comirnaty, saying it seems less likely to cause heart inflammation than Moderna’s rival shot Spikevax. The draft guidance from the Robert Koch Institute’s STIKO committee also says that pregnant women, regardless of their age, should get the Pfizer/BioNTech vaccine.
Outsourcing Pharma
NOVEMBER 10, 2021
Wasdell, a UK-based packaging and manufacturing provider in the UK, has opened a quality control laboratory in Dundalk to analyze products for its pharmaceutical clientele.
Pharma Times
NOVEMBER 9, 2021
iiCON’s lead partner LSTM will independently validate CN Bio’s novel lung and lung-liver models
Fierce Healthcare
NOVEMBER 10, 2021
Express Scripts launches option for employers to cover over-the-counter COVID-19 tests. pminemyer. Wed, 11/10/2021 - 16:05.
pharmaphorum
NOVEMBER 12, 2021
The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, the first antibody-based therapies for coronavirus to be backed for full approval in the EU. Ronapreve (casirivimab and imdevimab) – developed and distributed by Regeneron as REGN-COV in the US – has been recommended by the CHMP for the treatment and prevention of COVID-19 in people aged 12 years and older weighing at least 40kg.
Expert insights. Personalized for you.
142 
Let's personalize your content